U.S. markets closed
  • S&P Futures

    3,845.50
    +26.25 (+0.69%)
     
  • Dow Futures

    31,981.00
    +205.00 (+0.65%)
     
  • Nasdaq Futures

    12,404.00
    +106.75 (+0.87%)
     
  • Russell 2000 Futures

    2,219.70
    +18.90 (+0.86%)
     
  • Crude Oil

    65.18
    +0.13 (+0.20%)
     
  • Gold

    1,682.10
    +4.10 (+0.24%)
     
  • Silver

    25.30
    +0.03 (+0.12%)
     
  • EUR/USD

    1.1846
    -0.0007 (-0.06%)
     
  • 10-Yr Bond

    1.5960
    +0.0420 (+2.70%)
     
  • Vix

    25.47
    +0.81 (+3.28%)
     
  • GBP/USD

    1.3817
    -0.0005 (-0.03%)
     
  • USD/JPY

    109.1130
    +0.2120 (+0.19%)
     
  • BTC-USD

    52,606.96
    +1,082.09 (+2.10%)
     
  • CMC Crypto 200

    1,066.34
    +42.14 (+4.11%)
     
  • FTSE 100

    6,719.13
    +88.61 (+1.34%)
     
  • Nikkei 225

    28,825.79
    +82.54 (+0.29%)
     

Chembio Diagnostics (CEMI) Surges: Stock Moves 8.5% Higher

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Chembio Diagnostics, Inc. CEMI was a big mover last session, as the company saw its shares rise more than 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company—as the stock is now up 51.7% in the past one-month time frame.

The move came after the company received a contract from the Biomedical Advanced Research and Development Authority for the development of Rapid DPP Respiratory Antigen Panel and 510(k) submission of the Rapid DPP SARS-CoV-2 Antigen Test System.

The company has seen a mixed track record when it comes to no estimate revisions over the past few months, while the Zacks Consensus Estimate for the current quarter hasn’t been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Chembio Diagnostics, Inc. Price

Chembio Diagnostics, Inc. Price
Chembio Diagnostics, Inc. Price

Chembio Diagnostics, Inc. price | Chembio Diagnostics, Inc. Quote

Chembio Diagnostics currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

A better-ranked stock in the Medical - Products industry is Quidel Corporation QDEL, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

These Stocks Are Poised to Soar Past the Pandemic

The COVID-19 outbreak has shifted consumer behavior dramatically, and a handful of high-tech companies have stepped up to keep America running. Right now, investors in these companies have a shot at serious profits. For example, Zoom jumped 108.5% in less than 4 months while most other stocks were sinking.

Our research shows that 5 cutting-edge stocks could skyrocket from the exponential increase in demand for “stay at home” technologies. This could be one of the biggest buying opportunities of this decade, especially for those who get in early.

See the 5 high-tech stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Chembio Diagnostics, Inc. (CEMI) : Free Stock Analysis Report
 
Quidel Corporation (QDEL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research